Author

Richard O. Dolinar

Observed names: R Dolinar, R. DOLINAR, R. Dolinar, Richard Dolinar, Richard O Dolinar

Observed institutions: Brigham and Women's Hospital, Joslin Diabetes Center, Harvard University, Eli Lilly (United States), Duke University, Pfizer (United States), Morristown Medical Center, Diabetes & Endocrine Associates, Duke Medical Center, Heartland Alliance, University at Buffalo, State University of New York, University of California, Davis

OpenAlex ID: A5031560530

Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.

1985 · G S Eisenbarth, S Srikanta, et al. · PubMed · 131

Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of Type 1 (insulin-dependent) diabetic patients

1991 · P. Vardi, L. Crisa, et al. · Diabetologia · 119

Biosimilars naming, label transparency and authority of choice – survey findings among European physicians

2014 · Richard O Dolinar, Michael S Reilly · Generics and Biosimilars Initiative Journal · 44

The non-medical switching of prescription medications

2019 · Richard Dolinar, Christine G. Kohn, et al. · Postgraduate Medicine · 39

The Importance of Good Insulin Injection Practices in Diabetes Management

2009 · Richard Dolinar · US Endocrinology · 19

Testosterone-Producing Adrenal Adenoma in a Woman With Normal Urinary 17-Ketosteroid Levels

1983 · Richard Dolinar · JAMA · 15

A Guide to Follow-on Biologics and Biosimilars with a Focus on Insulin

2018 · Richard Dolinar, Frank Lavernia, et al. · Endocrine Practice · 13

Impact of Biosimilar Insulins on Clinical Practice

2014 · Richard O. Dolinar, Steve Edelman, et al. · Journal of Diabetes Science and Technology · 12

The future of biological therapy: a pathway forward for biosimilars

2013 · Richard Dolinar · Generics and Biosimilars Initiative Journal · 10

Monoclonal Antibodies to a Human Islet Cell Surface Glycoprotein: 4F2 and LC7-2*

1987 · S. SRIKANTA, M. TELEN, et al. · Endocrinology · 9

Pay for Performance Means Compliance-Based Care

2006 · Richard O. Dolinar, S. Luke Leininger · Journal of the American Medical Directors Association · 6

Pay-for-Performance or Compliance? A Second Opinion on Medicare Reimbursement

2006 · Richard Dolinar, S. Luke Leininger · Indiana Health Law Review · 4

Biosimilar Drugs Are Not Generics

2016 · Farhad Zangeneh, Richard Dolinar · Endocrine Practice · 3

WHO leadership in public safety on biosimilars to be commended

2013 · Richard O Dolinar · Generics and Biosimilars Initiative Journal · 2

Mountains뀀Ƞof뀀ȠChange뀀Ƞin뀀ȠPeriAnesthesia뀀ȠCare Flagstaff,뀀ȠAZ뀀Ƞ Program Topics: Professionalism, Cardiac Assessment, Native American Healthcare, Healthcare Reform, Diabetes

2014 · Jacque A. Crosson, Leaf K. Edmondson, et al.

Prior approval harms the doctor/patient relationship.

2004 · Richard O Dolinar · PubMed

Works count: 16

Citation count: 426

H-index: 9

I10-index: 9